And I guess I should chime in. When you said "good" in every sense of the word (re: my prediction that enrollment sped up) I should probably qualify that it does not mean "good" in terms of predicting trial efficacy outcome (for instance). It does mean, if the prediction is true, the first few patients made it through their initial treatment phase without serious enough side effects to derail the trial. In the end, you must do your own due diligence, and even if you think someone here knows what they are talking about, you must research it to draw your own conclusion.
News 
Market Data 
Discover 
AI
